We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+15.2%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$1.84B
AUM Growth
+$226M
Cap. Flow
+$18.1M
Cap. Flow %
0.98%
Top 10 Hldgs %
36.21%
Holding
2,856
New
200
Increased
717
Reduced
1,072
Closed
193
Avg Time Held Equity + Options
2.5 years
Top 10 Avg Time Held Equity + Options
1.7 years
Top 20 Avg Time Held Equity + Options
1.8 years
Avg Time Held Equity only
2.5 years
Top 10 Avg Time Held Equity only
1.7 years
Top 20 Avg Time Held Equity only
1.8 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 54.33%
2 Technology 13.72%
3 Financials 8.08%
4 Healthcare 7.07%
5 Consumer Discretionary 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TRST icon
2701
Trustco Bank Corp NY
TRST
$928M
$0 ﹤0.01%
8
– –
2020 Q2
2 quarters
TRTX icon
2702
TPG RE Finance Trust
TRTX
$454M
– –
-872
Closed -$7K –
TSI icon
2703
TCW Strategic Income Fund
TSI
$266M
– –
-1,600
Closed -$9K –
TVTX icon
2704
Travere Therapeutics
TVTX
$5.2B
– –
-94
Closed -$2K –
TWST icon
2705
Twist Bioscience
TWST
$9.27B
– –
-161
Closed -$12K –
TXRH icon
2706
Texas Roadhouse
TXRH
$11.2B
$0 ﹤0.01%
4
– –
2016 Q4
16 quarters
UA icon
2707
Under Armour Class C
UA
$2.06B
$0 ﹤0.01%
15
– –
2016 Q4
16 quarters
UAA icon
2708
Under Armour
UAA
$2.12B
– –
-272
Closed -$3K –
UBX icon
2709
DELISTED
Unity Biotechnology
UBX
$0 ﹤0.01%
+1
New +$48
2020 Q4
0 quarters
UEIC icon
2710
Universal Electronics
UEIC
$66.5M
– –
-19
Closed -$1K –
UFPT icon
2711
UFP Technologies
UFPT
$2.31B
– –
-31
Closed -$1K –
UNFI icon
2712
United Natural Foods
UNFI
$2.94B
– –
-830
Closed -$12K –
VNM icon
2713
VanEck Vietnam ETF
VNM
$461M
– –
-216
Closed -$3K –
VRNT icon
2714
DELISTED
Verint Systems
VRNT
$0 ﹤0.01%
6
– –
2016 Q4
16 quarters
VSAT icon
2715
Viasat
VSAT
$8.22B
– –
-13
Closed – –
VVX icon
2716
V2X
VVX
$2.16B
– –
-165
Closed -$6K –
WAFD icon
2717
WaFd
WAFD
$2.18B
– –
-327
Closed -$7K –
WINT icon
2718
DELISTED
Windtree Therapeutics
WINT
– –
0
– –
2020 Q2
2 quarters
WIW icon
2719
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$485M
– –
-416
Closed -$5K –
WKHS icon
2720
Workhorse Group
WKHS
$31.9M
– –
0
– –
2020 Q3
1 quarter
WMS icon
2721
Advanced Drainage Systems
WMS
$9.65B
$0 ﹤0.01%
5
– –
2020 Q2
2 quarters
WOOD icon
2722
iShares Global Timber & Forestry ETF
WOOD
$256M
– –
-1,385
Closed -$90K –
WRN icon
2723
Western Copper and Gold
WRN
$407M
$0 ﹤0.01%
6
– –
2016 Q4
16 quarters
WWW icon
2724
Wolverine World Wide
WWW
$1.61B
– –
-187
Closed -$5K –
XLRE icon
2725
State Street Real Estate Select Sector SPDR ETF
XLRE
$7.88B
– –
-69
Closed -$2K –

Similar funds

Parallel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Parallel Advisors held 2,856 positions worth $1.84B, up 14% from $1.62B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Parallel Advisors's Q4 2020 filing shows 200 new, 717 increased, 1,072 reduced and 193 closed positions. Its largest new stake was Inari Medical, Inc. Common Stock: 59,852 shares worth $5.22M. The largest sale was Microsoft, an estimated $18.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, down from 56% a quarter earlier, followed by Technology and Financials.

  • Parallel Advisors's largest Q4 2020 buy was Inari Medical, Inc. Common Stock: 59,852 shares worth $5.22M.
  • Parallel Advisors added most to iShares US Treasury Bond ETF in Q4 2020, an estimated $14.5M increase.
  • Parallel Advisors's biggest Q4 2020 reduction was Microsoft, cutting an estimated $18.3M.
  • Parallel Advisors fully exited Livongo Health, Inc. Common Stock in Q4 2020, selling an estimated $926K.
  • Parallel Advisors's ten largest holdings make up 36% of its $1.84B portfolio in Q4 2020.
  • Parallel Advisors opened 200 new positions and closed 193 in Q4 2020.
  • Parallel Advisors's portfolio value rose 14% quarter-over-quarter to $1.84B.

Based on Parallel Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.